NCT02492958: SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults |
|
|
| Completed | 2 | 136 | Japan | Staphylococcus aureus 4-antigen vaccine, SA4Ag, Placebo | Pfizer | Staphylococcal Infections | 09/16 | 09/16 | | |
NCT01364571: Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years |
|
|
| Completed | 1/2 | 456 | US | SA4Ag vaccine low dose, Blood draw, Colonization swab sample, SA4Ag vaccine mid dose, Blood sample, SA4Ag vaccine high dose, Placebo | Pfizer | Staphylococcal Infections | 01/13 | 01/13 | | |
NCT01643941: Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years |
|
|
| Completed | 1/2 | 284 | US | SA4Ag vaccine low dose, Blood draw, Colonization swab sample, SA4Ag vaccine mid dose, SA4Ag vaccine high dose, SA3Ag vaccine, Blood sample, Placebo, Colonization swab samples | Pfizer | Staphylococcal Infections | 05/13 | 03/14 | | |
